NANJING, China, Dec. 26, 2023 /PRNewswire/ -- PharmaBlock Sciences (Nanjing), Inc. (Stock code: 300725. SZSE), a global, fully integrated CRDMO company, focusing on innovative chemistry and low-carbon manufacturing, has announced the successful attainment of Energy Management System Certification (ISO 50001:2018) for its headquarters and R&D center in Nanjing, as well as its manufacturing facilities in Zhejiang and Shandong, China. This achievement illustrates PharmaBlock's ongoing dedication to lean operations, energy efficiency, and sustainable development.
PharmaBlock has been proactively improving its energy management systems, supporting The Paris Agreement and China's Carbon Peaking and Carbon Neutrality Goals. Following ISO 50001 international standard guidelines, the company has systematically established and implemented facilities and processes to reduce energy consumption, greenhouse gas emissions, and other environmental impacts. As stated in its inaugural ESG report published in early 2023, PharmaBlock commits to achieving a 20% reduction in energy consumption by 2030 as part of its sustainability goals, using 2022 as the baseline year.
Besides systematic and lean management, PharmaBlock's Technology Innovation Center (TIC) serves as a hub for exploring green, safe, and intelligent advanced pharmaceutical manufacturing model. It has developed and implemented a comprehensive suite of low-carbon technologies, featuring flow chemistry, micropacked bed hydrogenation, biocatalysis, heterogeneous catalysis, etc. Through green chemistry design, process optimization, integration of low-carbon technologies, and equipment engineering, the TIC is propelling PharmaBlock's commitment to sustainable development.
The company's efforts in low-carbon technology innovation have been acknowledged with the prestigious 2023 ACS CMO Excellence in Green Chemistry Award, which was offered for a project that applies continuous flow processes to produce a key intermediate used in API synthesis of various marketed and clinical drugs. This innovative approach has led to a substantial reduction in energy consumption, wastes, workspace, and labor operations.
In the future, PharmaBlock will continue to optimize energy-saving and emission reduction initiatives throughout its operations to enhance efficiency and reduce costs. Moreover, the company will maintain its focus on green development, promoting sustainable practices in the pharmaceutical R&D and manufacturing industry, and generating long-term value for customers, the industry, and society as a whole.
中国南京,2023年12月26日 /PRNewswire/--药石科学(南京)有限公司(股票代码:300725.SZSE)是一家专注于创新化学和低碳制造的全球性完全整合的CRDMO公司,已宣布其位于南京的总部和研发中心以及位于中国浙江和山东的制造工厂成功获得能源管理体系认证(ISO 50001:2018)。这一成就表明了PharmaBlock对精益运营、能源效率和可持续发展的持续承诺。
PharmaBlock一直在积极改善其能源管理系统,支持《巴黎协定》和中国的碳峰值和碳中和目标。根据ISO 50001国际标准指南,公司系统地建立和实施了设施和流程,以减少能耗、温室气体排放和其他环境影响。正如其在2023年初发布的首份ESG报告中指出的那样,PharmaBlock承诺以2022年为基准年,到2030年将能源消耗减少20%,这是其可持续发展目标的一部分。
除了系统和精益管理外,PharmaBlock的技术创新中心(TIC)还是探索绿色、安全和智能的先进药品制造模式的中心。它开发并实施了一整套低碳技术,包括流动化学、微包装床氢化、生物催化、异构催化等。通过绿色化学设计、工艺优化、低碳技术集成和设备工程,TIC正在推动PharmaBlock对可持续发展的承诺。
该公司在低碳技术创新方面的努力得到了久负盛名的2023年ACS CMO绿色化学卓越奖的认可,该奖项旨在利用连续流动工艺生产用于各种上市和临床药物API合成的关键中间体。这种创新方法显著减少了能耗、浪费、工作空间和劳动力运营。
未来,PharmaBlock将继续在整个运营过程中优化节能和减排举措,以提高效率并降低成本。此外,该公司将继续专注于绿色发展,促进药品研发和制造行业的可持续实践,为客户、行业和整个社会创造长期价值。